William Jones Dartora

William Jones Dartora

Auto-generated profile, based on publicly available information

William Jones Dartora

Brain Health Imaging Institute, Department of Radiology, Weill Cornell Medicine, New York, NY, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2024 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
SMS. M. A. Mehdi
S. M. A. Mehdi
ACA. P. Costa
A. P. Costa
CSConnie Svob
Connie Svob
LPL. Pan
L. Pan
WDW. J. Dartora
W. J. Dartora
LML. B. J. McIntire
L. B. J. McIntire
Chronic dysregulation of peripheral lipids has been found to be associated with depression and cognition, but their interaction has not been investigated. Growing evidence has highlighted the association between peripheral lipoprotein levels with depression and cognition with inconsistent results. We assessed the association between peripheral lipids, depression, and cognition while evaluating their potential interactions using robust clinically relevant predictors such as lipoprotein levels and chronic medical disorders that dysregulate lipoproteins. We report an association between peripheral lipids, depression, and cognition, suggesting a common underlying biological mechanism driven by lipid dysregulation in two independent studies. Analysis of a longitudinal study of a cohort at high or low familial risk for major depressive disorder (MDD) (n = 526) found metabolic diseases, including diabetes, hypertension, and other cardiovascular diseases, were associated with MDD and cognitive outcomes. Investigating a cross-sectional population survey of adults in the National Health and Nutrition Examination Survey 2011–2014 (NHANES) (n = 2377), depression was found to be associated with high density lipoprotein (HDL) and cognitive assessments. In the familial risk study, medical conditions were found to be associated with chronic lipid dysregulation and were significantly associated with MDD using the structural equation model. A positive association between chronic lipid dysregulation and cognitive scores was found in an exploratory analysis of the familial risk study. In a complementary study, analysis of NHANES revealed a positive association of HDL levels with cognition. Further analysis of the NHANES cohort indicated that depression status mediated the interaction between HDL levels and cognitive tests. Importantly, the protective effect of HDL on cognition was absent in those with depressive symptoms, which may ultimately result in worse outcomes leading to cognitive decline. These findings highlight the potential for the early predictive value of medical conditions with chronic lipid dyshomeostasis for the risk of depression and cognitive decline.

4 August 2025 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
MKMohammad Khalafi
Mohammad Khalafi
KSKiarash Shirbandi
Kiarash Shirbandi
LZLiangdong Zhou
Liangdong Zhou
TBTracy A. Butler
Tracy A. Butler
KCKewei Chen
Kewei Chen
GCGloria C. Chiang
Gloria C. Chiang
Diffusion Tensor Imaging along the Perivascular Space (DTI-ALPS) has emerged as a measure of cerebral interstitial fluid dynamics, a proposed component of the glymphatic system, which may provide insight into central nervous system fluid transport and waste clearance. Our study aimed to evaluate whether DTI-ALPS can serve as a reliable, noninvasive imaging biomarker of altered interstitial fluid dynamics across the Alzheimer's Disease (AD) continuum. We searched Scopus, Web of Science, and PubMed for articles published through October 2024. Studies were included if they reported the ALPS-index in AD, mild cognitive impairment (MCI), and healthy control groups. Studies were excluded if they lacked sufficient data or involved overlapping cohorts. Using standardized mean difference (SMD), we compared the ALPS-index in AD and MCI groups to healthy controls. We assessed the association between the ALPS index and cognitive function using a random-effects model. A qualitative risk bias assessment was conducted using the Newcastle-Ottawa Scale (NOS). Nineteen studies met the inclusion criteria. The overall ALPS index was significantly lower in AD subjects than in healthy controls (SMD = -1.07, 95% CI: -1.57 to -0.56). Statistically significant differences were also observed between AD and MCI subjects (SMD = -0.25, 95% CI: -0.40 to -0.10), as well as between MCI and healthy control subjects (SMD = -0.81, 95% CI: -1.57 to 0.06). Additionally, the ALPS index showed a statistically significant association with Mini-Mental State Examination scores (pooled correlation effect size = 0.43, 95% CI: 0.28 to 0.57). A negative correlation was also observed between the ALPS index and amyloid deposition on PET, with a pooled correlation effect size of -0.42 (95% CI: -0.66 to -0.19, p < 0.001). Potential limitations include heterogeneity across imaging protocols, variability in cognitive assessments, and possible publication bias. The DTI-ALPS technique showed significant differences among cognitive groups across the AD continuum and was associated with cognitive scores and brain amyloidosis. This provides further evidence that DTI-ALPS could be useful in detecting altered cerebral interstitial fluid dynamics in MCI and AD. AD= Alzheimer's disease; Aβ= beta-amyloid; PET= positron emission tomography; PiB= Pittsburgh Compound B; FBB= Florbetaben; CL= Centiloid.

1 September 2017 in Revista Cuidarte
Verified
Journal Article
Open access
PDF file
WDWilliam Jones Dartora
William Jones Dartora
ÉÂÉder Propp Ânflor
Éder Propp Ânflor
LSLetícia Ribeiro Pavão da Silveira
Letícia Ribeiro Pavão da Silveira
Prevalência do HIV no Brasil 2005-2015: dados do Sistema Único de Saúde

Verified
Journal Article
Open access
KWKrista Mineia Wartchow
Krista Mineia Wartchow
LRLeticia Rodrigues
Leticia Rodrigues
WDWilliam Jones Dartora
William Jones Dartora
RBRegina Biasibetti
Regina Biasibetti
Nicholas SelistreNicholas Selistre
Nicholas Selistre
O(On Behalf Of Alzheimer’s Disease Neuroimaging Initiative (Adni)
On Behalf Of Alzheimer’s Disease Neuroimaging Initiative (Adni)
While the greatest risk factor for Alzheimer’s disease (AD) is aging, women are disproportionately affected by the disease. Interestingly, the hippocampus and cerebellum exhibit gender-specific cytoarchitecture differences, which are associated with AD, despite the absence of a role in animal reproductive behavior or hormonal signaling. This study investigates the potential association of sex differences associated with AD by interrogating cerebellar and hippocampal volume in preclinical (MCI) as well as clinical phases of AD compared to cognitively normal patients (CN) and in an animal model of AD, the streptozotocin (STZ)-induced sporadic AD model. In order to investigate putative changes in cerebellum and hippocampus in a rat model of AD, we used a STZ-induced sporadic AD model at three different time points (2, 4, and 8 weeks) after surgery in male and female rats. Previous studies have reported hippocampal-dependent changes as well as sex-dependent behavioral and signaling effects in the STZ animal model of sporadic AD while our current study showed involvement of cerebellum-mediated changes. To interrogate the role of cerebellar volume in AD progression within the human context, we analyzed data available through the Alzheimer’s Disease Neuroimaging Initiative (ADNI). In a cross-sectional analysis, we observed that levels of peripheral Glial Acidic Fibrillary Protein (GFAP) (astrocytic protein) were associated negatively with cerebellar and hippocampal volumes (β = −0.002, p-value = 0.04; β = −6.721, p-value < 0.0001) and were associated with sex specific differences in males. Our analysis identified that the effect on hippocampal volume was earlier in disease stage, reinforcing the relevance of longitudinal alterations of cerebellum and hippocampus volume over time. The STZ animal model of sporadic AD, corroborated the progressive changes in hippocampal volume and more minor and temporally delayed involvement of the cerebellum volume changes which were dependent on sex. This suggests that cerebellar involvement may be secondary to hippocampal neurodegeneration, and both regional differences were dependent on sex. Due to the association with GFAP, our findings may be due to network astrocyte connection spread regardless of primary pathology. Overall, our study uncovers a novel role for cerebellum in AD in a model and in the human context.

22 June 2014 in Revista Cuidarte
Verified
Journal Article
Open access
PDF file
WDWilliam Jones Dartora
William Jones Dartora
KWKrista Minéia Wartchow
Krista Minéia Wartchow
AAAlba Luz Rodríguez Acelas
Alba Luz Rodríguez Acelas
Introdução: Os esteroides anabolizantes (EA) são derivados da testosterona, utilizados para tratar algumas doenças. Começou a ser utilizados por atletas, para o aumento de massa muscular e força física em atividades, porém nos últimos anos há um aumento de pessoas em uso de EA, jovens que praticam atividade física como meio de lazer, mas com o intuito de melhorar sua aparência acabam fazendo uso destas substâncias indiscriminadamente. O objetivo deste estudo foi refletir o uso indiscriminado de EA, e sua repercussão como um problema de saúde pública. Materiais e Métodos: Artigo de reflexão, que apresenta uma abordagem a partir da literatura e também da realidade sobre a perspectiva do problema de saúde pelo uso de anabolizantes por esportistas e jovens praticantes de atividade física. Resultados: A presente reflexão mostra que pessoas adeptas de EA, são esportistas, adolescentes e pessoas que gostam de manter uma imagem corporal baseada em estereótipos imposta pela sociedade. Discussão: O estereótipo criado pela sociedade atual e a busca pelo bom rendimento na atividade física, estimulam que as pessoas utilizem EA sem controle, gerando um problema que está crescendo gradualmente, sem que até hoje exista uma maior abordagem do tema por parte das autoridades governamentais. Conclusões: Apesar de existir um controle para a compra deste tipo de medicamento, este não é de todo efetivo, originando um alto risco no surgimento de doenças nos usuários, além do crescente número de adeptos sem controle na população. Portanto, necessita-se de mais estudos que abordem esta problemática, maior controle na comercialização destes produtos e intervenção por parte dos entes governamentais responsáveis. Palavras chave: Esteroides, Imagem Corporal, Anabolizantes. (Fonte: DeCS BIREME). Cómo citar este artículo: Jones Dartora W, Minéia Wartchow K, Rodríguez Acelas AL. O uso abusivo de esteroides anabolizantes como um problema de saúde pública. Rev Cuid. 2014; 5(1): 689-93.

1 August 2018 in Sao Paulo Medical Journal
Verified
Journal Article
Open access
PDF file
WDWilliam Jones Dartora
William Jones Dartora
MMMarcelo Krieger Maestri
Marcelo Krieger Maestri
MSMaria Inês Schmidt
Maria Inês Schmidt
BDBruce Duncan
Bruce Duncan
LCLloyd Chambless
Lloyd Chambless
VLVivian C. Luft
Vivian C. Luft
KEY WORDS: Microvessels; Retinal artery; Retinal vein; Reproducibility of results